PacBio Joins iHope Initiative as First Long-Read Genomic Sequencing Partner

MENLO PARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, long-read sequencing technologies, today announced a collaboration with iHope, a global ...
Nasdaq

PacBio Joins 1000 Genomes Long Read Sequencing Project to Enhance Human Genomics Research

PacBio has announced its participation in the 1000 Genomes Long Read Sequencing Project, contributing long-read transcriptome data to enhance this significant human genomics initiative. Through ...
Seeking Alpha

PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio

MENLO PARK, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has joined the 1000 Genomes Long Read ...

PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases

Detailed price information for Pacific Biosciences (PACB-Q) from The Globe and Mail including charting and trades.
Seeking Alpha

PacBio Launches Single-Cell Transcriptome Solution Ushering in a New Era of RNA Discovery

MAS-Seq Supports Isoform Research Using Single-Cell RNA Sequencing from 10x Genomics MENLO PARK, Calif., Oct. 20, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, ...

PacBio Completes Sale of Short-Read Sequencing Assets

PacBio received $48.1 million in net cash proceeds from the transaction. Under the terms of the agreement, Illumina assumed certain liabilities and granted a non-exclusive license certain intellectual ...
Hosted on MSN

PacBio stock up on HiFi sequencing adoption for major SUDC research

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, recently announced that its HiFi whole-genome sequencing technology has been adopted as a first-line approach in a major ...